TheEdgeResearch
Home / Stocks / GDTC

CytoMed Therapeutics Limited (GDTC)

NASDAQ Healthcare Biotechnology
$0.76 ▼ -2.33%
Market Cap
$8.9M
Sector
Healthcare
Industry
Biotechnology
Beta
0.05
52-Wk Range
0.68-2.12
CEO
Chee Kong Choo
Country
SG
Currency
USD

CytoMed Therapeutics Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Singapore, CE, SG. The stock last traded at $0.76, down 2.33% on the session, giving a market capitalisation of $8.9M. On trailing twelve-month figures it carries a trailing P/E of -2.22, a net margin of -730.3%. Its beta of 0.05 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.22
Price / Sales
16.00
Price / Book
2.33
EV / EBITDA
-2.18
Gross margin
-577.7%
Operating margin
-794.6%
Net margin
-730.3%
Return on equity
—
Debt / equity
0.09
Current ratio
2.64
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
42
IPO date
2023-04-14
Headquarters
Singapore, CE, SG
About CytoMed Therapeutics Limited

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.

Comparable companies

CytoMed Therapeutics Limited is most often compared with the following Healthcare names:

CLGNENLVLSTAMTVANCNANRSNNRXSPASGSONNXCUR
More research on GDTC
GDTC technical analysis GDTC TheEdge Score Compare against peers
Open full interactive analysis & DCF →